Search Results 771-780 of 18113 for Tuberculosis

1. Infectious Diseases! Clinical Trials - Mayo Clinic Research

   ... tuberculosis. Communities During COVID – Focus Groups Scottsdale/Phoenix, AZ; Jacksonville, FL; Rochester, MN. The study seeks to understand the impacts the ...

2. Flunisolide (inhalation route) - Side effects & dosage - Mayo Clinic

   Tuberculosis, untreated active or history of—Use with caution. This medicine can reduce the body's ability to fight off these infections. Infection or ...

3. A Study to Evaluate the Safety, Tolerability, and Determine the Optimal Dose for the Expansion Cohorts of VSV-IFNβ-NIS in Combination with Pembrolizumab in Patients with Refractory Solid Tumors - Mayo Clinic

   Known history of active TB (Bacillus tuberculosis). Any serious health condition, which, in the opinion of the investigator, would place the patient at ...

4. Fosamprenavir (oral route) - Side effects & dosage - Mayo Clinic

   Sometimes the immune system will start to fight infections that were hidden in your body, such as pneumonia or tuberculosis, or may result in a flare-up of ...

5. A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety and Effectiveness of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate-to-Severe Hidradenitis Suppurativa - Mayo Clinic

   Infected with Mycobacterium tuberculosis (TB). Have known immunodeficiency disorder or a first-degree relative with a hereditary immunodeficiency. Have any ...

6. Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas - Mayo Clinic

   History of tuberculosis, including those who may have completed prophylactic isoniazid (INH) therapy. Documented current central nervous system (CNS) ...

7. A Study to Evaluate the Effectiveness and Safety of P276-00 for Mantle Cell Lymphoma that has Returned and/or is Resistant to Treatment - Mayo Clinic

   ... tuberculosis, Hepatitis C or Hepatitis B; Pregnant or lactating women; Women of childbearing potential or men not willing to use at least 2 approved methods ...

8. Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis - Mayo Clinic

   Subjects with a history of tuberculosis or positive PPD skin test. 11. Subjects who have received administration of any live vaccine (other than intranasal ...

9. Budesonide (nasal route) - Side effects & dosage - Mayo Clinic

   Tuberculosis, active or history of—Can reduce the body's ability to fight off these infections. Injury to the nose, recent or; Nose surgery, recent or; Sores ...

10. Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma - Mayo Clinic

    Ongoing uncontrolled infections including tuberculosis;; Symptomatic congestive heart failure;; Unstable angina pectoris, cardiac arrhythmias and uncontrolled ...